LAVAL, Québec--(BUSINESS WIRE)--Altasciences is proud to support Alzamend Neuro, Inc. (Alzamend) in advancing a novel treatment for dementia related to Alzheimer’s disease (Alzheimer’s). In addition ...

Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press ...

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences, a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core ...

LAVAL, Québec, August 21, 2025--(BUSINESS WIRE)--Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. ("Steel"), to initiate a pivotal toxicology study for Fizurex™, a novel topical ...

Laval, Quebec-based Altasciences has acquired WCCT Global, a Cypress, California-based early-stage clinical research organization. No financial terms were disclosed. Altasciences, a CRO specializing ...

COPENHAGEN, Denmark, Feb. 22, 2021 /PRNewswire/ -- Novo Holdings A/S, a world-leading life science investor with a focus on long-term, sustainable value creation, today announced that it has agreed to ...

Canada’s Altasciences has penned a new deal that sees it snap up the preclinical testing business of SNBL USA. The buyout will add “comprehensive preclinical safety testing services” to Altasciences’ ...

Altasciences, a forward-thinking CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, announced today that they have ...

LAVAL, Quebec — Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. This transaction will support Altasciences’ goal of being a mid ...

FARGO — Altasciences, which performs clinical and preclinical research studies in the U.S. and Canada for biopharmaceutical firms, is closing up operations at its south Fargo office due to a slowdown ...

LAVAL, Quebec--(BUSINESS WIRE)--#CDMO--Altasciences, a fully integrated early phase CRO/CDMO has started the expansion of their CDMO facility in Philadelphia, PA. The additional 35,000-square-foot ...

LAVAL, Québec, March 28, 2025--(BUSINESS WIRE)--Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule ...